Sherman Ku received his PhD in molecular biology from The Scripps Research Institute after developing an iPSC-based disease model used for investigating the trinucleotide repeat expansion disease mechanism for Friedreich's ataxia. Afterwards, he continued on to the Allen Institute for Brain Science where he studied human brain development using engineered reporter iPSC lines, in vitro cortical neuronal differentiation, and various single-cell RNAseq-based viral lineage tracing techniques. Since joining Just-Evotec Biologics in 2016, Sherman has focused primarily on engineering CHO host cell lines with novel or improved functionality for biotherapeutic manufacturing.